Preventing and treating cancer in people with HIV
Consortium for Advancing Management and Prevention of Cancer in People with HIV
This program tests new prevention and treatment approaches to lower cancer risk and improve outcomes for people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11406607 on NIH RePORTER |
What this research studies
You can join clinical trials that test new cancer treatments and ways to prevent cancers that affect people with HIV. The program combines patient enrollment at a large network of clinics with lab studies of tumor biology and biospecimens. Sites are located in the U.S., sub-Saharan Africa, and Latin America, and the consortium has enrolled thousands of participants over many trials. The program also involves community advocates and trains researchers to make sure trials match patient needs.
Who could benefit from this research
Good fit: People living with HIV who have—or are at higher risk for—HIV-associated cancers (such as anal cancer) and who can enroll at one of the consortium's participating sites are ideal candidates.
Not a fit: People without HIV, those with cancers unrelated to HIV, or individuals who cannot access a participating site are unlikely to be eligible or directly benefit.
Why it matters
Potential benefit: If successful, this work could reduce cancer rates, improve treatment options, and increase survival and quality of life for people living with HIV.
How similar studies have performed: Yes; the AMC has run over 97 interventional trials with more than 10,000 participants and produced evidence that has changed clinical practice.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.